We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Smart Nanoparticles Deliver Selective Heating to Kill Tumors

By LabMedica International staff writers
Posted on 28 Jul 2016
Print article
Image: A team of scientists has discovered an organic ‘smart’ biodegradable nanoparticle, named PEARL, that uses light and heat in a controlled manner to target and destroy tumors with bigger precision (Photo courtesy of the University Health Network).
Image: A team of scientists has discovered an organic ‘smart’ biodegradable nanoparticle, named PEARL, that uses light and heat in a controlled manner to target and destroy tumors with bigger precision (Photo courtesy of the University Health Network).
Cancer researchers have demonstrated a novel type of "smart" nanoparticle that can destroy a tumor through selective heating while causing minimal damage to surrounding normal tissues.

Investigators at University Health Network (Toronto, Canada) described the use of PEARLs (photo-thermal enhancing auto-regulating liposomes) in a proof-of-concept paper that was published in the July 14, 2016, online edition of the journal Angewandte Chemie.

Photothermal therapy (PTT) is enhanced by the use of nanoparticles with a large optical absorption at the treatment wavelength. However, this comes at the cost of higher light attenuation that results in reduced depth of heating as well as larger thermal gradients, leading to potential over- and under-treatment in the target tissue. These limitations can be overcome by using PEARLs, which are based on thermochromic J-aggregate forming dye–lipid conjugates that reversibly alter their absorption above a predefined lipid phase-transition temperature.

The investigators showed - in nanoparticle solutions and in gel phantoms containing the nanoparticles - that under irradiation by near-infrared light, deeper layers of the target tissue reverted to the intrinsic optical absorption, halting the temperature rise and enabling greater light penetration and heat generation at depth.

Senior author Dr. Gang Zheng, professor of medical biophysics at the University Health Network, said, "Our smart nanoparticle is super cool. It can absorb light, generate heat, and ablate the tumor. It is a thermal sensor and once it reaches the desired ablation temperature of 55 degrees Celsius, it becomes invisible allowing the light to move deeper into more areas of tumor and repeat the treatment process. The result is a promising new way to heat and ablate larger volumes of tumor with minimal damage to surrounding tissues in a controlled and precise way. The next step is to conduct pre-clinical studies to test the concept further."

Related Links:
University Health Network


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more